Impact of pharmacotherapy follow up in the health-related quality of life of patients with

Descripción del Articulo

Was evaluated the impact that generates the intervention of the pharmacist in the health-related quality of life HRQL patients with diagnosis of essential arterial hypertension (AHT). They was from external doctor’s offices of the Cardiology Service and they received their medicines through the Chro...

Descripción completa

Detalles Bibliográficos
Autores: Ayala L, Liana K., Condezo M, Kelya, Juárez E, José R.
Formato: artículo
Fecha de Publicación:2010
Institución:Universidad Nacional Mayor de San Marcos
Repositorio:Revistas - Universidad Nacional Mayor de San Marcos
Lenguaje:español
OAI Identifier:oai:ojs.csi.unmsm:article/3230
Enlace del recurso:https://revistasinvestigacion.unmsm.edu.pe/index.php/farma/article/view/3230
Nivel de acceso:acceso abierto
Materia:Calidad de vida
calidad de vida relacionada a la salud
seguimiento farmacoterapéutico
hipertensión arterial.
Life quality health-related quality of life
pharmacotherapy follow-up
arterial hypertension.
id REVUNMSM_1f698ab8a6b1278b77fc992f16452652
oai_identifier_str oai:ojs.csi.unmsm:article/3230
network_acronym_str REVUNMSM
network_name_str Revistas - Universidad Nacional Mayor de San Marcos
repository_id_str
dc.title.none.fl_str_mv Impact of pharmacotherapy follow up in the health-related quality of life of patients with
Impacto del seguimiento farmacoterapéutico en la calidad de vida relacionada a la salud de pacientes con hipertension arterial
title Impact of pharmacotherapy follow up in the health-related quality of life of patients with
spellingShingle Impact of pharmacotherapy follow up in the health-related quality of life of patients with
Ayala L, Liana K.
Calidad de vida
calidad de vida relacionada a la salud
seguimiento farmacoterapéutico
hipertensión arterial.
Life quality health-related quality of life
pharmacotherapy follow-up
arterial hypertension.
title_short Impact of pharmacotherapy follow up in the health-related quality of life of patients with
title_full Impact of pharmacotherapy follow up in the health-related quality of life of patients with
title_fullStr Impact of pharmacotherapy follow up in the health-related quality of life of patients with
title_full_unstemmed Impact of pharmacotherapy follow up in the health-related quality of life of patients with
title_sort Impact of pharmacotherapy follow up in the health-related quality of life of patients with
dc.creator.none.fl_str_mv Ayala L, Liana K.
Condezo M, Kelya
Juárez E, José R.
author Ayala L, Liana K.
author_facet Ayala L, Liana K.
Condezo M, Kelya
Juárez E, José R.
author_role author
author2 Condezo M, Kelya
Juárez E, José R.
author2_role author
author
dc.subject.none.fl_str_mv Calidad de vida
calidad de vida relacionada a la salud
seguimiento farmacoterapéutico
hipertensión arterial.
Life quality health-related quality of life
pharmacotherapy follow-up
arterial hypertension.
topic Calidad de vida
calidad de vida relacionada a la salud
seguimiento farmacoterapéutico
hipertensión arterial.
Life quality health-related quality of life
pharmacotherapy follow-up
arterial hypertension.
description Was evaluated the impact that generates the intervention of the pharmacist in the health-related quality of life HRQL patients with diagnosis of essential arterial hypertension (AHT). They was from external doctor’s offices of the Cardiology Service and they received their medicines through the Chronic Patients Drugstore of the Navy Medical Center “Cirujano Mayor Santiago Távara”, during a period of six months, using the Dáder method of pharmacotherapy follow-up (PTF). 14 patients of 40 years old to more were included in the study, 71,4% were men and 28,6% women without another associate chronic pathology. Specific MINICHAL questionnaire was used in order to determine the HRQL to the beginning of the study, during and later of pharmaceutical intervention. It was detected 29 drug-related problems (DRP): 66% of them related mainly to the necessity, 24% to effectiveness and 10% to security. Were solved 24 drug related problems (DRPs), (75%) that demonstrates the degree of acceptance of the pharmaceutical recommendations to eliminate the causes of DRPs and justify the incorporation of the PTF as essential part in the function of the hospital pharmacist. The communication of the interventions were done in major percentage between pharmacist-patient (87,5%), using both the verbal form as the written one, and pharmacist-patient-phycicians (12,5%) using the written form. At the end of the study, 57% of the patients had controlled their arterial pressure, in comparison with 42% of the patients at the beginning of the study. Was conclude that the HRQL is positively influenced by pharmacist intervention through PTF.
publishDate 2010
dc.date.none.fl_str_mv 2010-12-31
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/farma/article/view/3230
10.15381/ci.v13i2.3230
url https://revistasinvestigacion.unmsm.edu.pe/index.php/farma/article/view/3230
identifier_str_mv 10.15381/ci.v13i2.3230
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/farma/article/view/3230/2698
dc.rights.none.fl_str_mv Derechos de autor 2010 Liana K. Ayala L, Kelya Condezo M, José R. Juárez E
https://creativecommons.org/licenses/by-nc-sa/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2010 Liana K. Ayala L, Kelya Condezo M, José R. Juárez E
https://creativecommons.org/licenses/by-nc-sa/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Farmacia y Bioquímica
publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Farmacia y Bioquímica
dc.source.none.fl_str_mv Ciencia e Investigación; Vol. 13 Núm. 2 (2010); 78-81
Ciencia e Investigación; Vol. 13 No. 2 (2010); 78-81
1609-9044
1561-0861
reponame:Revistas - Universidad Nacional Mayor de San Marcos
instname:Universidad Nacional Mayor de San Marcos
instacron:UNMSM
instname_str Universidad Nacional Mayor de San Marcos
instacron_str UNMSM
institution UNMSM
reponame_str Revistas - Universidad Nacional Mayor de San Marcos
collection Revistas - Universidad Nacional Mayor de San Marcos
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1795238295181983744
spelling Impact of pharmacotherapy follow up in the health-related quality of life of patients withImpacto del seguimiento farmacoterapéutico en la calidad de vida relacionada a la salud de pacientes con hipertension arterialAyala L, Liana K.Condezo M, KelyaJuárez E, José R.Calidad de vidacalidad de vida relacionada a la saludseguimiento farmacoterapéuticohipertensión arterial.Life quality health-related quality of lifepharmacotherapy follow-uparterial hypertension.Was evaluated the impact that generates the intervention of the pharmacist in the health-related quality of life HRQL patients with diagnosis of essential arterial hypertension (AHT). They was from external doctor’s offices of the Cardiology Service and they received their medicines through the Chronic Patients Drugstore of the Navy Medical Center “Cirujano Mayor Santiago Távara”, during a period of six months, using the Dáder method of pharmacotherapy follow-up (PTF). 14 patients of 40 years old to more were included in the study, 71,4% were men and 28,6% women without another associate chronic pathology. Specific MINICHAL questionnaire was used in order to determine the HRQL to the beginning of the study, during and later of pharmaceutical intervention. It was detected 29 drug-related problems (DRP): 66% of them related mainly to the necessity, 24% to effectiveness and 10% to security. Were solved 24 drug related problems (DRPs), (75%) that demonstrates the degree of acceptance of the pharmaceutical recommendations to eliminate the causes of DRPs and justify the incorporation of the PTF as essential part in the function of the hospital pharmacist. The communication of the interventions were done in major percentage between pharmacist-patient (87,5%), using both the verbal form as the written one, and pharmacist-patient-phycicians (12,5%) using the written form. At the end of the study, 57% of the patients had controlled their arterial pressure, in comparison with 42% of the patients at the beginning of the study. Was conclude that the HRQL is positively influenced by pharmacist intervention through PTF.Se evaluó el impacto de la intervención del farmacéutico en la calidad de vida relacionada a la salud (CVRS) de pacientes con hipertensión arterial esencial (HTA), que acuden a los consultorios externos del servicio de cardiología y reciben sus medicamentos a través de la Farmacia de Pacientes Crónicos del Centro Médico Naval “Cirujano Mayor Santiago Távara”, durante un periodo de seis meses, utilizando el método Dáder de seguimiento farmacoterapéutico (SFT). Se incluyeron en el estudio 14 pacientes de 40 años a más, 71,4% varones y 28,6% mujeres, sin otra patología crónica asociada. Se empleó el cuestionario específico MINICHAL para determinar la CVRS al inicio del estudio, durante y después de la intervención. Se detectaron 29 problemas relacionados con los medicamentos (PRM): 66% relacionados con la necesidad, 24% con la efectividad y 10% con la seguridad. Se resolvieron 24 PRM (75%), lo que demuestra el grado de aceptación de las recomendaciones farmacéuticas para eliminar las causas prevenibles de los PRM y justifican la incorporación del SFT como parte esencial de la función del farmacéutico hospitalario. La comunicación de las intervenciones se hicieron en mayor porcentaje entre farmacéutico-paciente (87,5%), tanto verbal como escrita, y farmacéutico-paciente-médico (12,5%) en forma escrita. Los resultados mostraron al 57% de los pacientes con presión arterial controlada al culminar el estudio, en comparación con el 42% al inicio de éste. Se concluye que, la CVRS se ve influenciada positivamente por la intervención del farmacéutico en el SFT.Universidad Nacional Mayor de San Marcos, Facultad de Farmacia y Bioquímica2010-12-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistasinvestigacion.unmsm.edu.pe/index.php/farma/article/view/323010.15381/ci.v13i2.3230Ciencia e Investigación; Vol. 13 Núm. 2 (2010); 78-81Ciencia e Investigación; Vol. 13 No. 2 (2010); 78-811609-90441561-0861reponame:Revistas - Universidad Nacional Mayor de San Marcosinstname:Universidad Nacional Mayor de San Marcosinstacron:UNMSMspahttps://revistasinvestigacion.unmsm.edu.pe/index.php/farma/article/view/3230/2698Derechos de autor 2010 Liana K. Ayala L, Kelya Condezo M, José R. Juárez Ehttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessoai:ojs.csi.unmsm:article/32302020-04-27T09:47:22Z
score 13.982926
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).